SAREPTA THERAPEUTICS, INC. (SRPT) Return on equity 2016–2025
SAREPTA THERAPEUTICS, INC. (SRPT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-62.5%FY2025 · since FY2016: -79.4% → -62.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -62.5% | -77.9 pp |
| FY2024 | 15.4% | +77.8 pp |
| FY2023 | -62.4% | +120.4 pp |
| FY2022 | -182.7% | -137.6 pp |
| FY2021 | -45.1% | +27.6 pp |
| FY2020 | -72.7% | +14.7 pp |
| FY2019 | -87.4% | -52.3 pp |
| FY2018 | -35.1% | -28.6 pp |
| FY2017 | -6.4% | +73.0 pp |
| FY2016 | -79.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More SRPT financial trends
SRPT RevenueSRPT Net incomeSRPT Net marginSRPT Gross profitSRPT Gross marginSRPT Operating incomeSRPT Operating marginSRPT Operating cash flowSRPT Free cash flowSRPT Capital expendituresSRPT Stock buybacksSRPT Dividends paidSRPT Total assetsSRPT Total liabilitiesSRPT Shareholders’ equitySRPT overview →